Avenue Therapeutics (ATXI) Misses Q2 EPS by 39c
Tweet
Share
E-mailGet Alerts ATXI Hot Sheet
Join SI Premium – FREE
Avenue Therapeutics (NASDAQ: ATXI) reported Q2 EPS of ($0.52), $0.39 worse than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Avenue Therapeutics (ATXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Capitol Federal Financial names William Skrobacz Jr. as president
- Paychex (PAYX) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
